Updates ·
Health notices · Sunday 15 November
3 notices from the agencies today, in plain words, each with the original linked.
Class II recall of antiseptic hand soap due to manufacturing issues
FDA · Recall
If you used the recalled antiseptic hand soap (1 gallon/3.8 L), the US Food and Drug Administration says it is being recalled as a Class II action after CGMP deviations.
CGMP refers to manufacturing quality rules that help ensure products are made consistently. Deviations may mean the soap’s quality is not as expected.
This notice is published 2026-11-04, and the soap was distributed US-wide.
FDA approval for Lialda to treat ulcerative colitis
FDA · Approval
If you have mildly to moderately active ulcerative colitis, the FDA has approved Lialda to help bring symptoms under control (induction).
The FDA also approved Lialda to help maintain remission (keeping symptoms away) for adults.
For children, Lialda is approved to treat mildly to moderately active ulcerative colitis if they weigh at least 24 kg.
Oxytocin product recalled due to sterility concern
FDA · Recall
If you have been prescribed oxytocin injection in a 500 mL 0.9% sodium chloride single-use container, this product may be affected.
The FDA notice says there was lack of assurance of sterility for the specific listed oxytocin product distributed across the United States.
If you are unsure whether your treatment used this product, ask the clinician or pharmacy involved in your care about the product used.
Where this comes from
- Class II recall of antiseptic hand soap due to manufacturing issuesUS Food and Drug Administration — enforcement report
- FDA approval for Lialda to treat ulcerative colitisUS Food and Drug Administration — Drugs@FDA
- Oxytocin product recalled due to sterility concernUS Food and Drug Administration — enforcement report
Each notice above is summarised from the agency's own publication, linked beside it. Nothing here is a finding of ours.